Clinical Trials Browser

Phase 2 × Recruiting × Tiragolumab × Clear all

NCT05681039 2026-03-02

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT05483400 2025-03-30

TIRACAN

Phase 2 Recruiting

DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

NCT03708224 2025-01-28

Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Phase 2 Recruiting

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT06003621 2024-11-15

MoST-TAP

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06342037 2024-09-19

TONIC-3

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms